About Bioline
Bioline is a company based in London (United Kingdom) founded in 1992 was acquired by Meridian Bioscience in July 2010. It operates as a Direct-to-Consumer (D2C) and Professional Services. The company has 42 employees as of October 31, 2019. Bioline offers products and services including SensiFAST™ Kits, JetSeq™ Kits, and MyTaq™ Polymerases. Bioline operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
- Headquarter London, United Kingdom
- Employees 42 as on 31 Oct, 2019
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Meridian Bioscience
-
Annual Revenue
$68.23 M (USD)314as on Sep 03, 2020
-
Net Profit
$39.17 M (USD)686as on Sep 03, 2020
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
42
as on Oct 31, 2019
-
Acquired by
Meridian Bioscience
(Jul 20, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioline
Bioline offers a comprehensive portfolio of products and services, including SensiFAST™ Kits, JetSeq™ Kits, and MyTaq™ Polymerases.
Reagents for fast and sensitive qPCR applications are provided.
Library preparation kits for NGS sequencing are offered.
DNA polymerases for robust PCR amplification are supplied.
Funding Insights of Bioline
Detailed funding history for Bioline
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Bioline
Bioline has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Meridian Bioscience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Molecular diagnostic device and kits
|
Locked | Locked | Locked |
Investor details for Bioline
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioline
Investment portfolio details for Bioline
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioline
Detailed financials for Bioline
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioline Comparisons
Peer comparison for Bioline
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioline
Bioline operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Develops tools and products for research and clinical application
|
|
| Locked | Locked | Locked |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
Detailed competitors of Bioline
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioline
Complete news archive for Bioline
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioline
Bioline was founded in 1992.
Bioline is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
As of Oct 31, 2019, the latest employee count at Bioline is 42.
Annual revenue of Bioline is $68.23M as on Sep 03, 2020.
Bioline, a part of Meridian Bioscience, is focused on the development and supply of reagents for molecular biology applications. Products are designed for PCR, qPCR, and next-generation sequencing, supporting research in areas such as agricultural biotechnology, cancer research, drug discovery, epigenetics, molecular diagnostics, and stem cell research. Solutions are offered to facilitate gene expression analysis, genotyping, biomarker analysis, and nucleic acid purification across various scientific sectors.
Bioline's top competitors include Abcam, Sino Biological and Meridian Bioscience.
Bioline offers SensiFAST™ Kits, JetSeq™ Kits, and MyTaq™ Polymerases.
Bioline has 1 investor. Key investors include Meridian Bioscience.